Literature DB >> 2078496

Emesis during past pregnancy: a new prognostic factor in chemotherapy-induced emesis.

M Martin1, E Diaz-Rubio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078496     DOI: 10.1093/oxfordjournals.annonc.a057695

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study.

Authors:  Olivier Mir; Jean-Philippe Durand; Pascaline Boudou-Rouquette; Julie Giroux; Romain Coriat; Anatole Cessot; Stanislas Ropert; François Goldwasser; Raphaël Gaillard
Journal:  Support Care Cancer       Date:  2012-05-30       Impact factor: 3.603

Review 2.  Methodological issues in antiemetic studies.

Authors:  M Aapro
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

3.  Methodology and assessment in clinical anti-emetic research: a meta-analysis of outcome parameters.

Authors:  G R Morrow
Journal:  Br J Cancer Suppl       Date:  1992-12

4.  Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.

Authors:  C Seynaeve; J Schuller; K Buser; H Porteder; S Van Belle; P Sevelda; D Christmann; M Schmidt; H Kitchener; D Paes
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

5.  Impact of tumour burden on chemotherapy-induced nausea and vomiting.

Authors:  T J Hursti; E Avall-Lundqvist; S Börjeson; M Fredrikson; C J Fürst; G Steineck; C Peterson
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.